(Q37398272)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

title

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

0 references

0 references

Christine Lebrun-Frenay

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Pierre Clavelou

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

author name string

Ayman Tourbah

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Gilles Edan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Michel Clanet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Caroline Papeix

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Sandra Vukusic

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Jerome De Sèze

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Marc Debouverie

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Olivier Gout

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Gilles Defer

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

David-Axel Laplaud

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Thibault Moreau

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Pierre Labauge

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Bruno Brochet

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Frédéric Sedel

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Jean Pelletier

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

MS-SPI study group

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

language of work or name

1 reference

1 September 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

22 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

page(s)

1719-1731

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis

22 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098693

Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098693

High doses of biotin in chronic progressive multiple sclerosis: a pilot study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098693

Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098693

Defining the clinical course of multiple sclerosis: the 2013 revisions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098693

Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098693

Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098693

Timed 25-foot walk: direct evidence that improving 20% or greater is clinically meaningful in MS.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098693

Will the real multiple sclerosis please stand up?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098693

Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098693

Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098693

Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098693

Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098693

A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098693

Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098693

Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098693

Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098693

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098693

Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5098693

Cladribine and progressive MS: Clinical and MRI outcomes of a multicenter controlled trial

2 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1177%2F1352458516667568

Positive and negative interference in immunoassays following biotin ingestion: a pharmacokinetic study

21 January 2018

1 reference

12 December 2020

Relapses and progression of disability in multiple sclerosis

1 reference

12 December 2020

New multiple sclerosis phenotypic classification

1 reference

12 December 2020

Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS

1 reference

12 December 2020

Identifiers

DOI

10.1177/1352458516667568

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27589059%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

PubMed publication ID

27589059

1 reference